Literature DB >> 20333557

Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine.

Issam El Ghazi1, Wen S Sheng, Shuxian Hu, Brian G Reilly, James R Lokensgard, R Bryan Rock, Phillip K Peterson, George L Wilcox, Ian M Armitage.   

Abstract

Microglial cells play a major role in host defense of the central nervous system. Once activated, several functional properties are up-regulated including migration, phagocytosis, and secretion of inflammatory mediators such as cytokines and chemokines. Little, if anything, is known about the metabolic changes that occur during the activation process. High-resolution (1)H nuclear magnetic resonance spectra obtained from perchloric acid extracts of human microglial cell cultures exposed to lipopolysaccharide (LPS) or morphine were used to both identify and quantify the metabolites. We found that human microglia exposed to LPS had increased concentrations of glutamate and lactate, whereas the cells exposed to morphine had decreased concentrations in creatinine, taurine, and thymine. Glutamate and creatinine were the key metabolites differentiating between the two stimuli. These results are discussed in terms of activation and differences in the inflammatory response of human microglial cells to LPS and morphine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333557      PMCID: PMC4115445          DOI: 10.1007/s11481-010-9197-8

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  37 in total

Review 1.  Microglia.

Authors:  Denise van Rossum; Uwe-Karsten Hanisch
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

2.  Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Authors:  Axel Nimmerjahn; Frank Kirchhoff; Fritjof Helmchen
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

3.  The effects of repeated endotoxin exposure on rat brain metabolites as measured by ex vivo 1HMRS.

Authors:  Sulie L Chang; Christine C Cloak; Lorenc Malellari; Linda Chang
Journal:  J Neuroimmunol       Date:  2005-09       Impact factor: 3.478

Review 4.  Microglia as a pharmacological target in infectious and inflammatory diseases of the brain.

Authors:  R Bryan Rock; Phillip K Peterson
Journal:  J Neuroimmune Pharmacol       Date:  2006-06       Impact factor: 4.147

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Differential production of and migratory response to beta chemokines by human microglia and astrocytes.

Authors:  P K Peterson; S Hu; J Salak-Johnson; T W Molitor; C C Chao
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 7.  The role of microglia and macrophages in the pathophysiology of the CNS.

Authors:  G Stoll; S Jander
Journal:  Prog Neurobiol       Date:  1999-06       Impact factor: 11.685

8.  Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport.

Authors:  Hideyuki Takeuchi; Tetsuya Mizuno; Guiqin Zhang; Jinyan Wang; Jun Kawanokuchi; Reiko Kuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

9.  Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes.

Authors:  Wen S Sheng; Shuxian Hu; Xinan Min; Guy A Cabral; James R Lokensgard; Phillip K Peterson
Journal:  Glia       Date:  2005-01-15       Impact factor: 7.452

10.  Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity.

Authors:  Li Qian; Kai Soo Tan; Sung-Jen Wei; Hung-Ming Wu; Zongli Xu; Belinda Wilson; Ru-Bin Lu; Jau-Shyong Hong; Patrick M Flood
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

View more
  4 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

2.  Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.

Authors:  Christina Mueller; Joanne C Lin; Sulaiman Sheriff; Andrew A Maudsley; Jarred W Younger
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

3.  Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2.

Authors:  Righi Valeria; Schenetti Luisa; Mucci Adele; Benatti Stefania; Tascedda Fabio; Brunello Nicoletta; Pariante M Carmine; Alboni Silvia
Journal:  J Neuroimmune Pharmacol       Date:  2015-11-05       Impact factor: 4.147

4.  Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer's disease models.

Authors:  Marie-Christine Pardon; Maria Yanez Lopez; Ding Yuchun; Małgorzata Marjańska; Malcolm Prior; Christopher Brignell; Samira Parhizkar; Alessandra Agostini; Li Bai; Dorothee P Auer; Henryk M Faas
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.